Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era
- PMID: 28397377
- DOI: 10.1002/uog.17487
Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era
Abstract
Objectives: The main aim of this study was to assess the proportion and type of congenital anomalies, both structural and chromosomal, that can be detected at an early scan performed at 12-13 weeks' gestation, compared with at the 20-week structural anomaly scan offered under the present screening policy. Secondary aims were to evaluate the incidence of false-positive findings and ultrasound markers at both scans, and parental choice regarding termination of pregnancy (TOP).
Methods: Sonographers accredited for nuchal translucency (NT) measurement were asked to participate in the study after undergoing additional training to improve their skills in late first-trimester fetal anatomy examination. The early scans were performed according to a structured protocol, in six ultrasound practices and two referral centers in the north-east of The Netherlands. All women opting for the combined test (CT) or with an increased a-priori risk of fetal anomalies were offered a scan at 12-13 weeks' gestation (study group). All women with a continuing pregnancy were offered, as part of the 'usual care', a 20-week anomaly scan.
Results: The study group consisted of 5237 women opting for the CT and 297 women with an increased a-priori risk of anomalies (total, 5534). In total, 51 structural and 34 chromosomal anomalies were detected prenatally in the study population, and 18 additional structural anomalies were detected after birth. Overall, 54/85 (63.5%) anomalies were detected at the early scan (23/51 (45.1%) structural and all chromosomal anomalies presenting with either an increased risk at first-trimester screening or structural anomalies (31/34)). All particularly severe anomalies were detected at the early scan (all cases of neural tube defect, omphalocele, megacystis, and multiple severe congenital and severe skeletal anomalies). NT was increased in 12/23 (52.2%) cases of structural anomaly detected at the early scan. Of the 12 cases of heart defects, four (33.3%) were detected at the early scan, five (41.7%) at the 20-week scan and three (25.0%) after birth. False-positive diagnoses at the early scan and at the 20-week scan occurred in 0.1% and 0.6% of cases, respectively, whereas ultrasound markers were detected in 1.4% and 3.0% of cases, respectively. After first- or second-trimester diagnosis of an anomaly, parents elected TOP in 83.3% and 25.8% of cases, respectively.
Conclusions: An early scan performed at 12-13 weeks' gestation by a competent sonographer can detect about half of the prenatally detectable structural anomalies and 100% of those expected to be detected at this stage. Particularly severe anomalies, often causing parents to choose TOP, are amenable to early diagnosis. The early scan is an essential part of modern pregnancy care. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
Keywords: chromosomal anomalies; early diagnosis; first-trimester ultrasound; nuchal translucency; screening for congenital anomalies; structural anomalies.
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
Comment in
-
Reply.Ultrasound Obstet Gynecol. 2018 Oct;52(4):550-551. doi: 10.1002/uog.20091. Ultrasound Obstet Gynecol. 2018. PMID: 30284364 No abstract available.
-
Re: Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.Ultrasound Obstet Gynecol. 2018 Oct;52(4):550. doi: 10.1002/uog.20090. Ultrasound Obstet Gynecol. 2018. PMID: 30284366 No abstract available.
Similar articles
-
[Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].Akush Ginekol (Sofiia). 2004;43(3):3-10. Akush Ginekol (Sofiia). 2004. PMID: 15341249 Bulgarian.
-
Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.Ultrasound Obstet Gynecol. 2019 Oct;54(4):468-476. doi: 10.1002/uog.20844. Ultrasound Obstet Gynecol. 2019. PMID: 31408229
-
Screening for structural fetal anomalies during the nuchal translucency ultrasound examination.Am J Obstet Gynecol. 2007 Aug;197(2):181.e1-5. doi: 10.1016/j.ajog.2007.03.057. Am J Obstet Gynecol. 2007. PMID: 17689643
-
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study.Health Technol Assess. 2025 May;29(22):1-250. doi: 10.3310/NLTP7102. Health Technol Assess. 2025. PMID: 40455571 Free PMC article.
-
Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations.Cochrane Database Syst Rev. 2024 May 9;5(5):CD014715. doi: 10.1002/14651858.CD014715.pub2. Cochrane Database Syst Rev. 2024. PMID: 38721874 Free PMC article. Review.
Cited by
-
Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.BMC Pregnancy Childbirth. 2022 Oct 20;22(1):782. doi: 10.1186/s12884-022-05110-2. BMC Pregnancy Childbirth. 2022. PMID: 36266611 Free PMC article.
-
Termination of pregnancy after a prenatal diagnosis of congenital diaphragmatic hernia: Factors influencing the parental decision process.Prenat Diagn. 2023 Jan;43(1):95-101. doi: 10.1002/pd.6274. Epub 2022 Dec 4. Prenat Diagn. 2023. PMID: 36443507 Free PMC article.
-
Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?Prenat Diagn. 2020 Jan;40(2):197-205. doi: 10.1002/pd.5590. Epub 2019 Nov 27. Prenat Diagn. 2020. PMID: 31697852 Free PMC article.
-
Factors associated with common and atypical chromosome abnormalities after positive combined first-trimester screening in Chinese women: a retrospective cohort study.BMC Pregnancy Childbirth. 2019 Feb 4;19(1):55. doi: 10.1186/s12884-019-2205-y. BMC Pregnancy Childbirth. 2019. PMID: 30717698 Free PMC article.
-
Patient-friendly integrated first trimester screening by NIPT and fetal anomaly scan.Mol Cytogenet. 2021 Jan 9;14(1):4. doi: 10.1186/s13039-020-00525-y. Mol Cytogenet. 2021. PMID: 33422094 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials